Cargando…
Overcoming the Adverse Effects of Everolimus to Achieve Maximum Efficacy in the Treatment of Inoperable Breast Cancer: A Review of 11 Cases at Our Hospital
Everolimus is an effective treatment for advanced and/or metastatic breast cancer, especially in hormone receptor-positive cases. However, adverse events have prevented considerable numbers of clinicians from using this drug. Herein, we reviewed our clinical experiences and endeavored to identify pa...
Autores principales: | Yoshida-Ichikawa, Yuko, Tanabe, Masahiko, Tokuda, Emi, Shimizu, Hideo, Horimoto, Yoshiya, Miura, Kayo, Saito, Mitsue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103349/ https://www.ncbi.nlm.nih.gov/pubmed/30140215 http://dx.doi.org/10.1159/000490787 |
Ejemplares similares
-
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
por: Horimoto, Yoshiya, et al.
Publicado: (2014) -
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
por: Horimoto, Yoshiya, et al.
Publicado: (2018) -
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
por: Horimoto, Yoshiya, et al.
Publicado: (2016) -
Clinical remission of an inoperable malignant insulinoma by the combination treatment with octreotide and everolimus
por: Akahori, Hiroshi
Publicado: (2019) -
Intrinsic subtype distribution should vary according to institutions
por: Horimoto, Yoshiya, et al.
Publicado: (2020)